Analysts think ARTL stock price could increase by 106%
Jul 09, 2025, 11:25 AM
3.30%
What does ARTL do
Artelo Biosciences, a clinical-stage biopharmaceutical company based in Solana Beach, California, focuses on developing therapeutics targeting lipid-signaling pathways and the endocannabinoid system. Its key programs include ART27.13 for anorexia and ART26.12 for cancer, pain, and anxiety.
4 analysts think ARTL stock price will increase by 105.75%. The current median analyst target is $33.66 compared to a current stock price of $16.36. The lowest analysts target is $30.30 and the highest analyst target is $37.80.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
